Evaluation of Changes in Depression Levels of Bruxism Patients Treated With Botulinum Toxin-A


Erdil D., BAĞIŞ N., EREN H., CAMGÖZ M., ORHAN K.

JOURNAL OF ADVANCED ORAL RESEARCH, vol.12, no.2, pp.200-205, 2021 (ESCI) identifier

Abstract

Aim: Bruxism is defined as the involuntary recurrent masticatory muscle activity characterized by gnashing, grinding, clenching of teeth, and/or pushing the mandible. Factors creating its etiology are peripheral (morphological) or central (physiopathological and physiological), and exogenous. Recently, among physiological factors, depression and bruxism were considered to be related. A definitive treatment method does not exist for bruxism; however, botulinum toxin-A (BT-A) application is an up-to-date and effective way of treatment. The present study is aimed to evaluate the levels of depression in bruxism patients treated with BT-A application.